BiotechTube

caspofungin acetate

Phase 3Completed
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Fungal Infection

Conditions

Fungal Infection

Trial Timeline

Jun 1, 2005 → May 1, 2006

NCT ID
NCT00379964

About caspofungin acetate

caspofungin acetate is a phase 3 stage product being developed by Merck for Fungal Infection. The current trial status is completed. This product is registered under clinical trial identifier NCT00379964. Target conditions include Fungal Infection.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (6)

NCT IDPhaseStatus
NCT00635648Phase 3Completed
NCT00330395Phase 2Completed
NCT00250432Phase 3Completed
NCT00379964Phase 3Completed
NCT00292071Phase 2Completed
NCT00082524Phase 2Completed

Competing Products

20 competing products in Fungal Infection

See all competitors
ProductCompanyStageHype Score
BSG005Alkem LaboratoriesPhase 1/2
41
MicafunginAstellas PharmaPhase 1
33
MicafunginAstellas PharmaPre-clinical
23
amphotericin B liposomal (Ambisome)Astellas PharmaApproved
85
Parenteral micafungin application + Other parenteral antifungal drugsAstellas PharmaPre-clinical
23
Isavuconazonium sulfate + Voriconazole + PosaconazoleAstellas PharmaPre-clinical
23
MicafunginAstellas PharmaPre-clinical
23
MicafunginAstellas PharmaPre-clinical
23
FluconazoleAstellas PharmaPre-clinical
23
MicafunginAstellas PharmaPhase 1
33
Micafungin + PlaceboAstellas PharmaPhase 3
77
Posaconazole + Voriconazole + PlaceboMerckPhase 3
77
caspofungin acetate + Comparator: Micafungin sodiumMerckPhase 3
77
PosaconazoleMerckPhase 1
33
PosaconazoleMerckApproved
85
Posaconazole IV 6 mg/kg + Posaconazole PFS 6 mg/kgMerckPhase 2
52
Posaconazole oral suspension 40 mg/mLMerckPre-clinical
23
Posaconazole 12 mg/kg/day BID + Posaconazole 18 mg/kg/day BID + Posaconazole 18 mg/kg/day TID + Posaconazole 12 mg/kg/day TIDMerckPhase 1
33
caspofungin acetateMerckPhase 2
52
PosaconazoleMerckPhase 1
33

Other Products from Merck

DuleraApproved
85
ImipenemApproved
85
Mavenclad®Approved
85
raltegravir + PlaceboApproved
85
alendronate sodiumApproved
85